GENEVA, July 9 -- ASCENTAWITS PHARMACEUTICALS, LTD. filed a patent application (CN2026/070034) for “METHOD FOR TREATING PATIENTS WITH DRUG TOLERANCE BY AKR1C3 ENZYME-ACTIVATED COMPOUND”. With publication no. WO/2026/145755, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/675
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....